Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Clinical Outcome Study of Minimally Invasive Decompression for Lumbar Spinal Stenosis (MEDLLSS)

18 agosto 2008 aggiornato da: Far Eastern Memorial Hospital

Clinical Study of Microendoscopic Decompressive Laminotomy for Treatment of Lumbar Spinal Stenosis

The study is a prospective outcome study to evaluate the effectiveness and treatment outcomes of microendoscopic decompressive laminotomy (MEDL) with objective evaluation tools. The patients who fulfill the selection criteria will be enrolled to collect the pre-operative clinical data including demographic data, image studies, and functional evaluation for neurological symptoms and disability.

The patient will receive MEDL and post-operative follow-up will be arranged at 1 week, 1 month, 6 months, and 12 months after the operation. All the collected data will be analyzed to evaluate the efficacy and treatment results of MEDL.

Panoramica dello studio

Stato

Sconosciuto

Descrizione dettagliata

The patients undergoing microendoscopic decompressive laminotomy (MEDL) for lumbar spinal stenosis (LSS) between will be enrolled in this prospective study. The patients included must fulfill the following selection criteria:

  • neurogenic claudication or radicular leg pain with associated neurologic signs referring to the LSS syndrome;
  • moderate to severe spinal canal stenosis shown on cross-sectional imaging such as MRI or CT scan;
  • failure of conservative treatment for at least three months.

The patients who presents with either mechanical low back pain or segmental instability. Mechanical lower back pain is defined as pain that was induced by posture change, or that prevents the patient from sitting or standing for more than 30 minutes. Patients are considered to have segmental instability if they had isthmic spondylolisthesis, degenerative spondylolisthesis with more than 4 mm of translation or intervertebral angle reversal on dynamic radiographs.18 Surgical techniques

All the surgical procedures will be performed by a single surgeon (J. P.). The patients is positioned prone on the Relton-Hall frame after general anesthesia. Decompression is done under the endoscope with the tubular retraction system METRx (Medtronics, Minneapolis, MN). For patients with unilateral neurological symptoms, we will perform unilateral laminotomy and foraminotomy. For patients with bilateral neurological symptoms, we will performe unilateral laminotomy for bilateral decompression (ULBD) to decompress the central canal and bilateral lateral recesses.

When performing multiple-level decompression, the skin incision will be centered at the midpoint between selected intervertebral disc levels. The incision can be mobilized one level above or below after releasing the underlying connective tissues. Then we can set up the tubular retractor system through separate muscular portals for each level. For patients with small stature, we can perform a three-level surgery through a single surgical wound, just as the same size as we perform the single-level surgery.

All the patients will have routine AP, lateral, dynamic lateral radiographs pre-operatively, six months after the surgery, and at final follow-up. Post-operative instability is defined as progression of listhesis or scoliosis on dynamic radiographs.

Every patient will MR images of the lumbar spine before the surgery. The severity of stenosis is classified according to the cross sectional area of the dura sac at the axial plane on T1-weighted MR images-severe stenosis for less than 76 mm2, moderate stenosis for between 76 and 100 mm2, and mild stenosis for more than 100 mm2. When MRI is contraindicated, CT-myelography will be used instead.

Outcomes assessment will done with Oswestry Disability Index (ODI) for the overall disability and the Japanese Orthopedic Association (JOA) score for the clinical symptoms and signs. The patients will receive evaluation before the surgery, at six months, and at the final follow-up examination. The range of ODI is 100 ~ 0 with a lower index corresponding to a better result. Significant improvement is defined as more than 15 points of improvement after the treatment. The range of JOA score is -3 ~ 29 with a higher score corresponding to a better result. The improvement rate based on JOA score is calculated as follows: (pre-operative score - post-operative score)/(29 - pre-operative score) × 100%. The clinical results are classified into four grades by the improvement rate: excellent (more than 75%), good (between 51% and 75%), fair (between 26% and 50%), and poor (less than 26%). The success of treatment is defined as more than 25% improvement rate in JOA score.20 At the final follow-up, we will inquire each patient if he or she is satisfied with the treatment results.

The data about the pre-operative comorbidities, intra-operative, peri-operative, and post-operative complications will be retrieved from medical chart review.

Distribution of gender, age, clinical characteristics (coexistence of spondylolisthesis or scoliosis, severity of stenosis, and levels of decompression), and self-assessed satisfaction by the binary outcome of treatment (success or not, based on the JOA score; significant improvement of not, base on the ODI) will be tabulated. Fisher exact test will be preformed to compare the difference between the two groups. Odds ratios will be calculated by using the univariate logistic regression. Variables with two-sided p-value less than 0.05 were considered as significant factors associated with successful treatment. All statistical analyses are performed with statistical software, SAS version 9.1 (SAS Institute Inc, Cary, NC).

Tipo di studio

Osservativo

Iscrizione (Anticipato)

60

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Luoghi di studio

      • Taipei, Taiwan, 220
        • Reclutamento
        • Far-Eastern Memorial Hospital
        • Investigatore principale:
          • Jwo-Luen Pao, MD
        • Contatto:
          • Jwo-Luen Pao, MD
          • Numero di telefono: 2314 +886-2-89667000
          • Email: drpao@yahoo.com
        • Contatto:

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

40 anni e precedenti (Adulto, Adulto più anziano)

Accetta volontari sani

No

Sessi ammissibili allo studio

Tutto

Metodo di campionamento

Campione di probabilità

Popolazione di studio

The patients with degenerative lumbar spinal stenosis who failed conservative treatment.

Descrizione

Inclusion Criteria:

  • neurogenic claudication or radicular leg pain with associated neurologic signs referring to the LSS syndrome
  • moderate to severe spinal canal stenosis shown on cross-sectional imaging such as MRI or CT scan
  • failure of conservative treatment for at least three months

Exclusion Criteria:

  • mechanical low back pain or segmental instability

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Investigatori

  • Investigatore principale: Jwo-Luen Pao, MD, Far-Eastern Memorial Hospital, Taipei, Taiwan

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio

1 gennaio 2008

Completamento primario (Anticipato)

1 dicembre 2008

Completamento dello studio (Anticipato)

1 dicembre 2008

Date di iscrizione allo studio

Primo inviato

18 agosto 2008

Primo inviato che soddisfa i criteri di controllo qualità

18 agosto 2008

Primo Inserito (Stima)

19 agosto 2008

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Stima)

19 agosto 2008

Ultimo aggiornamento inviato che soddisfa i criteri QC

18 agosto 2008

Ultimo verificato

1 agosto 2008

Maggiori informazioni

Termini relativi a questo studio

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

3
Sottoscrivi